512 related articles for article (PubMed ID: 10925965)
21. Molecular evaluation of ablative therapy of Barrett's oesophagus.
Hage M; Siersema PD; Vissers KJ; Steyerberg EW; Haringsma J; Kuipers EJ; van Dekken H
J Pathol; 2005 Jan; 205(1):57-64. PubMed ID: 15586364
[TBL] [Abstract][Full Text] [Related]
22. Failure of Nd-YAG photocoagulation therapy as treatment for Barrett's oesophagus--a pilot study.
Luman W; Lessels AM; Palmer KR
Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):627-30. PubMed ID: 8853248
[TBL] [Abstract][Full Text] [Related]
23. Argon plasma coagulation for non-dysplastic Barrett's epithelium: a hard act to follow.
Bozymski EM
Am J Gastroenterol; 2007 May; 102(5):1128-9; author reply 1129-30. PubMed ID: 17489788
[No Abstract] [Full Text] [Related]
24. Ablation of Barrett's epithelium by endoscopic argon plasma coagulation in combination with high-dose omeprazole.
Schulz H; Miehlke S; Antos D; Schentke KU; Vieth M; Stolte M; Bayerdörffer E
Gastrointest Endosc; 2000 Jun; 51(6):659-63. PubMed ID: 10840296
[TBL] [Abstract][Full Text] [Related]
25. Randomized trial of argon plasma coagulation versus endoscopic surveillance for barrett esophagus after antireflux surgery: late results.
Bright T; Watson DI; Tam W; Game PA; Astill D; Ackroyd R; Wijnhoven BP; Devitt PG; Schoeman MN
Ann Surg; 2007 Dec; 246(6):1016-20. PubMed ID: 18043104
[TBL] [Abstract][Full Text] [Related]
26. Long-term clinical and pathologic response of Barrett's esophagus after antireflux surgery.
O'Riordan JM; Byrne PJ; Ravi N; Keeling PW; Reynolds JV
Am J Surg; 2004 Jul; 188(1):27-33. PubMed ID: 15219481
[TBL] [Abstract][Full Text] [Related]
27. Effect of up to 3 years of high-dose lansoprazole on Barrett's esophagus.
Sampliner RE
Am J Gastroenterol; 1994 Oct; 89(10):1844-8. PubMed ID: 7942680
[TBL] [Abstract][Full Text] [Related]
28. Thermal ablation of Barrett's esophagus: a heated debate.
Spechler SJ
Am J Gastroenterol; 2006 Aug; 101(8):1770-2. PubMed ID: 16928252
[TBL] [Abstract][Full Text] [Related]
29. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
[TBL] [Abstract][Full Text] [Related]
30. KTP laser ablation of Barrett's esophagus after anti-reflux surgery results in long-term loss of intestinal metaplasia. Potassium-titanyl-phosphate.
Bowers SP; Mattar SG; Waring PJ; Galloway K; Nasir A; Pascal R; Hunter JG
Surg Endosc; 2003 Jan; 17(1):49-54. PubMed ID: 12364985
[TBL] [Abstract][Full Text] [Related]
31. Stepwise radical endoscopic resection is effective for complete removal of Barrett's esophagus with early neoplasia: a prospective study.
Peters FP; Kara MA; Rosmolen WD; ten Kate FJ; Krishnadath KK; van Lanschot JJ; Fockens P; Bergman JJ
Am J Gastroenterol; 2006 Jul; 101(7):1449-57. PubMed ID: 16863545
[TBL] [Abstract][Full Text] [Related]
32. Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: immediate and mid term results.
Van Laethem JL; Cremer M; Peny MO; Delhaye M; Devière J
Gut; 1998 Dec; 43(6):747-51. PubMed ID: 9824599
[TBL] [Abstract][Full Text] [Related]
33. Ablation of nonneoplastic Barrett's mucosa using argon plasma coagulation with concomitant esomeprazole therapy (APBANEX): a prospective multicenter evaluation.
Manner H; May A; Miehlke S; Dertinger S; Wigginghaus B; Schimming W; Krämer W; Niemann G; Stolte M; Ell C
Am J Gastroenterol; 2006 Aug; 101(8):1762-9. PubMed ID: 16817835
[TBL] [Abstract][Full Text] [Related]
34. KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus.
Gossner L; May A; Stolte M; Seitz G; Hahn EG; Ell C
Gastrointest Endosc; 1999 Jan; 49(1):8-12. PubMed ID: 9869716
[TBL] [Abstract][Full Text] [Related]
35. Effects of low-power argon plasma coagulation thermoablation of Barrett's epithelium on oesophageal motility.
Basu KK; Talwar V; de Caestecker JS
Eur J Gastroenterol Hepatol; 2006 Jul; 18(7):733-7. PubMed ID: 16772830
[TBL] [Abstract][Full Text] [Related]
36. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus.
Pech O; Behrens A; May A; Nachbar L; Gossner L; Rabenstein T; Manner H; Guenter E; Huijsmans J; Vieth M; Stolte M; Ell C
Gut; 2008 Sep; 57(9):1200-6. PubMed ID: 18460553
[TBL] [Abstract][Full Text] [Related]
37. A randomised controlled trial of ablation of Barrett's oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results.
Sharma P; Wani S; Weston AP; Bansal A; Hall M; Mathur S; Prasad A; Sampliner RE
Gut; 2006 Sep; 55(9):1233-9. PubMed ID: 16905695
[TBL] [Abstract][Full Text] [Related]
38. Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness.
Ragunath K; Krasner N; Raman VS; Haqqani MT; Phillips CJ; Cheung I
Scand J Gastroenterol; 2005 Jul; 40(7):750-8. PubMed ID: 16118910
[TBL] [Abstract][Full Text] [Related]
39. Stepwise radiofrequency ablation of Barrett's esophagus preserves esophageal inner diameter, compliance, and motility.
Beaumont H; Gondrie JJ; McMahon BP; Pouw RE; Gregersen H; Bergman JJ; Boeckxstaens GE
Endoscopy; 2009 Jan; 41(1):2-8. PubMed ID: 19160152
[TBL] [Abstract][Full Text] [Related]
40. Neodymium:yttrium-aluminum garnet contact laser ablation of Barrett's high grade dysplasia and early adenocarcinoma.
Weston AP; Sharma P
Am J Gastroenterol; 2002 Dec; 97(12):2998-3006. PubMed ID: 12492182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
